Literature DB >> 21565673

Cushing's syndrome: all variants, detection, and treatment.

Susmeeta T Sharma1, Lynnette K Nieman.   

Abstract

Diagnosis of Cushing's syndrome involves a step-wise approach and establishing the cause can be challenging. Several pathogenic mechanisms have been proposed for glucocorticoid-induced hypertension, including a functional mineralocorticoid excess state, upregulation of the renin angiotensin system, and deleterious effects of cortisol on the vasculature. Surgical excision of the cause of excess glucocorticoids remains the optimal treatment. Antiglucocorticoid and antihypertensive agents and steroidogenesis inhibitors can be used as adjunctive treatment modalities in preparation for surgery and in cases where surgery is contraindicated or has not led to cure. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565673      PMCID: PMC3095520          DOI: 10.1016/j.ecl.2011.01.006

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  61 in total

1.  Pressor responsiveness in corticosteroid-induced hypertension in humans.

Authors:  M Pirpiris; K Sudhir; S Yeung; G Jennings; J A Whitworth
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

2.  Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones.

Authors:  C Klett; D Ganten; W Hellmann; M Kaling; G U Ryffel; T Weimar-Ehl; E Hackenthal
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

3.  Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome.

Authors:  F Fallo; A Paoletta; F Tona; M Boscaro; N Sonino
Journal:  J Intern Med       Date:  1993-12       Impact factor: 8.989

4.  Circadian blood pressure variations in endocrine disorders.

Authors:  C Spieker; M Barenbrock; K H Rahn; W Zidek
Journal:  Blood Press       Date:  1993-03       Impact factor: 2.835

5.  Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.

Authors:  M A Magiakou; G Mastorakos; E H Oldfield; M T Gomez; J L Doppman; G B Cutler; L K Nieman; G P Chrousos
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

6.  Glucocorticoids and atrial natriuretic factor receptors on vascular smooth muscle.

Authors:  K Yasunari; M Kohno; K Murakawa; K Yokokawa; T Takeda
Journal:  Hypertension       Date:  1990-11       Impact factor: 10.190

7.  Morbidity and mortality in Cushing's disease: an epidemiological approach.

Authors:  J Etxabe; J A Vazquez
Journal:  Clin Endocrinol (Oxf)       Date:  1994-04       Impact factor: 3.478

8.  Sleep architecture and sleep apnea in patients with Cushing's disease.

Authors:  J E Shipley; D E Schteingart; R Tandon; M N Starkman
Journal:  Sleep       Date:  1992-12       Impact factor: 5.849

9.  Glucocorticoid increases angiotensin II type 1 receptor and its gene expression.

Authors:  A Sato; H Suzuki; M Murakami; Y Nakazato; Y Iwaita; T Saruta
Journal:  Hypertension       Date:  1994-01       Impact factor: 10.190

10.  No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.

Authors:  J Kreutzer; I Jeske; B Hofmann; I Blumcke; R Fahlbusch; M Buchfelder; R Buslei
Journal:  Clin Neuropathol       Date:  2009 Nov-Dec       Impact factor: 1.368

View more
  17 in total

1.  Neural Regulation of the Stress Response: The Many Faces of Feedback.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Cell Mol Neurobiol       Date:  2012-02-01       Impact factor: 5.046

2.  Management of Cushing syndrome in children and adolescents: experience of a single tertiary centre.

Authors:  Maria Güemes; Philip G Murray; Caroline E Brain; Helen A Spoudeas; Catherine J Peters; Peter C Hindmarsh; Mehul T Dattani
Journal:  Eur J Pediatr       Date:  2016-05-12       Impact factor: 3.183

Review 3.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 4.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

5.  Steroid as double edged sword; a catastrophic event in the rural part of Nepal.

Authors:  Sandhya Kiran Neupane; Prakash Paudel Jaishi; Divyaa Koirala; Prabhat Kiran Neupane
Journal:  Ann Med Surg (Lond)       Date:  2022-09-21

6.  Endocrine hypertension - Cushing's syndrome.

Authors:  Yashpal Singh; Narendra Kotwal; A S Menon
Journal:  Indian J Endocrinol Metab       Date:  2011-10

7.  Inhalational Steroids and Iatrogenic Cushing's Syndrome.

Authors:  Raveendran A V
Journal:  Open Respir Med J       Date:  2014-01-31

Review 8.  Cushing's syndrome: epidemiology and developments in disease management.

Authors:  Susmeeta T Sharma; Lynnette K Nieman; Richard A Feelders
Journal:  Clin Epidemiol       Date:  2015-04-17       Impact factor: 4.790

Review 9.  Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.

Authors:  Maria Fleseriu; Frederic Castinetti
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

10.  Anaesthetic management of a patient with Cushing's syndrome and non-compaction cardiomyopathy for adrenal tumour resection.

Authors:  Akilandeswari Manickam; Aruna Parameswari; Mahesh Vakamudi
Journal:  Indian J Anaesth       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.